Comments
Loading...
Vor Biopharma (VOR) Forecast
NewsEarningsVor Biopharma (VOR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVor Biopharma (NASDAQ:VOR) Stock Quotes, Forecast and News Summary
Vor Biopharma Stock (NASDAQ: VOR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vor Biopharma (VOR) stock?
You can purchase shares of Vor Biopharma (NASDAQ:VOR) through any online brokerage.
Who are Vor Biopharma (VOR) competitors?
Other companies in Vor Biopharma’s space includes: Macrogenics (NASDAQ:MGNX), Innate Pharma (NASDAQ:IPHA), Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE) and Genelux (NASDAQ:GNLX).
What is the forecast, or price target, for Vor Biopharma (VOR) stock?
Vor Biopharma has a consensus price target of $11.75.
What is the current price for Vor Biopharma (VOR)?
The stock price for Vor Biopharma (NASDAQ: VOR) is $1.385 last updated February 21, 2025 at 2:01 PM EST.
Does Vor Biopharma (VOR) pay a dividend?
There are no upcoming dividends for Vor Biopharma.
When is Vor Biopharma (NASDAQ:VOR) reporting earnings?
Vor Biopharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Vor Biopharma (VOR) going to split?
There is no upcoming split for Vor Biopharma.
What sector and industry does Vor Biopharma (VOR) operate in?
Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.